Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

WAY-100135 (CAS 149055-79-8)

0.0(0)
Write a reviewAsk a question

Application:
WAY-100135 is a selective and potent SR-1A (5-HT1A receptor) antagonist
CAS Number:
149055-79-8
Molecular Weight:
468.46
Molecular Formula:
C24H33N3O22HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

WAY-100135 is a selective antagonist of the 5-HT6 serotonin receptor. It functions by binding to the receptor and blocking the action of serotonin, a neurotransmitter involved in various physiological processes. By inhibiting the 5-HT6 receptor, WAY-100135 modulates the release of other neurotransmitters, such as dopamine and acetylcholine, in the brain. This modulation can potentially impact cognitive function and memory processes. At the molecular level, WAY-100135′s interaction with the 5-HT6 receptor alters intracellular signaling pathways, leading to downstream effects on neuronal activity. WAY-100135′s mode of action involves targeting the 5-HT6 receptor and interfering with its normal function, potentially influencing cognitive processes in experimental models.


WAY-100135 (CAS 149055-79-8) References

  1. WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801.  |  Wedzony, K., et al. 2000. Neuropsychopharmacology. 23: 547-59. PMID: 11027920
  2. Role of nitric oxide on motor behavior.  |  Del Bel, EA., et al. 2005. Cell Mol Neurobiol. 25: 371-92. PMID: 16047547
  3. Development of theta rhythm in hippocampal formation slices perfused with 5-HT1A antagonist, (S)WAY 100135.  |  Kazmierska, P. and Konopacki, J. 2015. Brain Res. 1625: 142-50. PMID: 26358147
  4. (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.  |  Carli, M., et al. 1995. Eur J Pharmacol. 283: 133-9. PMID: 7498302
  5. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.  |  Routledge, C., et al. 1995. Eur J Pharmacol. 276: 281-4. PMID: 7601215
  6. Antagonism of (+)WAY 100135 to behavioral, hypothermic and corticosterone effects induced by 8-OH-DPAT.  |  Przegaliński, E., et al. 1994. Pol J Pharmacol. 46: 21-7. PMID: 7981767
  7. The novel selective and silent 5-HT1A receptor antagonist (+)-WAY-100135 aggravates dystonic movements in a mutant hamster model.  |  Löscher, W. and Richter, A. 1994. Eur J Pharmacol. 255: 235-8. PMID: 8026548
  8. The effects of WAY-100135 and 8-hydroxy-2-(di-n-propylamino)tetralin on feeding in the rat.  |  Hartley, JE. and Fletcher, A. 1994. Eur J Pharmacol. 252: 329-32. PMID: 8162954
  9. The antagonist actions of WAY-100135 and its enantiomers on 5-HT1A receptor-mediated hyperpolarization of the rat isolated superior cervical ganglion.  |  Rhodes, KF., et al. 1993. Naunyn Schmiedebergs Arch Pharmacol. 348: 225-7. PMID: 8232599
  10. Characterization of the serotonin1A receptor antagonist activity of WAY-100135 and spiperone.  |  Escandon, NA., et al. 1994. J Pharmacol Exp Ther. 268: 441-7. PMID: 8301586
  11. Effects of the 5-HT1A antagonist (+)-WAY-100135 on murine social and agonistic behavior.  |  Bell, R., et al. 1996. Pharmacol Biochem Behav. 54: 159-67. PMID: 8728553
  12. WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.  |  Fornal, CA., et al. 1996. J Pharmacol Exp Ther. 278: 752-62. PMID: 8768728
  13. (+)-WAY 100135, a partial agonist, at native and recombinant 5-HT1B/1D receptors.  |  Davidson, C., et al. 1997. Br J Pharmacol. 121: 737-42. PMID: 9208142
  14. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.  |  Nakai, K., et al. 1998. Neurosci Res. 31: 23-9. PMID: 9704975
  15. GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.  |  Chaouloff, F., et al. 1998. Neuropharmacology. 37: 1159-67. PMID: 9833646

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

WAY-100135, 5 mg

sc-364647
5 mg
$92.00

WAY-100135, 25 mg

sc-364647A
25 mg
$399.00